PENNINGTON, N.J., March 12, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral...
Hence then, the article about zynext ventures invests in illexcor therapeutics to advance novel oral therapy for sickle cell disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease )
Also on site :
- Saudi Arabia to unify LPG gas cylinder prices nationwide from January 2026
- Two dozen killed in Ukrainian strike on Russian New Year’s celebration – governor
- Volunteer in Iran’s Revolutionary Guard reportedly killed during widening protests